A: Clinical trials suggest Retatrutide may work slightly faster due to its triple action, achieving ~24% weight loss in 48 weeks, compared to Tirzepatides ~21% in 72 weeks

Common side effects (5% or more of patients) Nausea Diarrhea Vomiting Constipation Abdominal pain Reduced appetite Indigestion or acid reflux Fatigue Mild injection site reactions (redness, itching, or bruising) Serious side effects (rare but require immediate medical attention) Pancreatitis: severe, persistent abdominal pain that may radiate to the back, often with nausea or vomiting Gallbladder problems: upper right abdominal pain, fever, jaundice, or unusual stool color Severe allergic reactions: rash, swelling of the face or throat, difficulty breathing Kidney issues: often related to dehydration from prolonged vomiting or diarrhea Diabetic retinopathy complications in patients with pre-existing diabetic eye disease (a known risk specific to rapid A1C reduction) Severe hypoglycemia when used in combination with insulin or sulfonylureas Increased heart rate at rest Boxed warning: Semaglutide caused thyroid C-cell tumors in animal studies

Lipo C makes the process more efficient once those conditions are in place
specifically, lycopene capsules and intralesional injected betamethasone were comparatively effective in increasing the mouth opening in patients at stage I, while betamethasone was more effective than lycopene in stage II, by contrast, lycopene was more potent than betamethasone in stage III